Skip to Main Content


This podcast is produced by pharmacy faculty to supplement study material and provide relevant drug and professional topics. We're hoping that our real-life clinical pearls and discussions will help you stay up-to-date and improve your pharmacy knowledge.

How Do I Listen?

HelixTalk is available via iTunes (or by searching for HelixTalk), by subscribing to our RSS feed, or by listening to any episode in your browser (below).

HelixTalk Episodes

HelixTalk Episode #78 - Transitioning from School to Practice - Advice for New Practitioners

Date posted: May 15, 2018, 6:00 am

In this episode, we interview Janeen Winnike, Dean of the Office of Students Affairs at the RFUMS College of Pharmacy, regarding transitions from a student life to a practitioner life. With her previous role as an HR official within a large community pharmacy chain, she offers some “do’s and don’ts” for students transitioning into new practitioners.

HelixTalk Episode #77 - PE: Not Just a Class in Junior High -- Top 5 Clinical Pearls about Pulmonary Embolism

Date posted: April 24, 2018, 6:00 am

In this episode, we discuss five clinical pearls about pulmonary embolism ranging from PE diagnosis, classification, and treatment. We specifically examine when and how alteplase is given for PE and its use with concurrent anticoagulation.

HelixTalk Episode #76 - The New Move: Treating Tardive Dyskinesia

Date posted: April 3, 2018, 6:00 am

In this episode, we discuss two new agents (valbenazine and deutetrabenazine) -- the first of their kind to receive FDA approval to manage tardive dyskinesia most commonly associated with antipsychotic use.

HelixTalk Episode #75 - Taking a break: perioperative management of anticoagulants and antiplatelets, Part II

Date posted: March 13, 2018, 6:00 am

In the previous episodes, we discussed how we should evaluate a patient’s bleeding and clotting risks as well as looked at recommendation for management for various anticoagulants. In this episode, we will continue the discussion to management of antiplatelets as well as when to resume both antiplatelets and anticoagulants following a procedure.